Thromb Haemost 1986; 55(01): 047-050
DOI: 10.1055/s-0038-1661444
Original Article
Schattauer GmbH Stuttgart

Hemostatic Parameters in Newborn - I. Effect of Gestation and Rate of Intrauterine Growth

B Dube
*   Department of Pathology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India
,
R K Dube
*   Department of Pathology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India
,
V Bhargava
Department of Pediatrics, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India
,
J K Kolindewala
Department of Pediatrics, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India
,
V L N Kota
Department of Pediatrics, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India
,
B K Das
Department of Pediatrics, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India
› Author Affiliations
Further Information

Publication History

Received 17 April 1985

Accepted 21 October 1985

Publication Date:
19 July 2018 (online)

Summary

The present study comprises of 208 term, 159 preterm and 18 post-term neonates born to mothers with no history of drug intake or any disease likely to effect coagulation of the newborn. PT, TT and KCCT were relatively prolonged and plasma fibrinogen reduced to varying degree in newborns (as compared to adults). There was further prolongation of TT and reduction in plasma fibrinogen levels amongst preterm newborns as compared to term babies; TT was more prolonged amongst post-term babies also. PT was significantly more prolonged till 30 weeks of gestation, after which a near plateau was formed. KCCT showed significant improvement after 33 weeks and a further trend to normalisation after 38 weeks of gestation. Serum FDP values showed too much of variation for any meaningful statistical analysis but generally FDPs were higher in preterm babies. Intrauterine growth rate had no significant effect on these parameters amongst preterms -similar values for SGA (small for gestational age), AGA (appropriate for gestational age) and LGA (large for gestational age). On the other hand, amongst term babies SGA neonates had significantly prolonged PT and low plasma fibrinogen as compared to AGA; LGA babies also showed more prolongation of TT as compared to AGA.

 
  • References

  • 1 Cade JF, Hirsh J, Martin M. Placental barrier to coagulation factors, its relevance to the coagulation defect at birth and to haemorrhage in the newborn. Br Med J 1969; 2: 281-283
  • 2 Bleyer WA, Breckenridge RT. Studies on the detection of adverse drug reactions in the newborn II. The effects of prenatal aspirin on newborn hemostasis. JAMA 1970; 213: 2049-2053
  • 3 Karpatkin M. Diagnosis and management of disseminated intravascu-lar coagulation. Pediatr Clin North Am 1971; 18: 23-38
  • 4 Bleyer WA, Hakami N, Shepard TH. The development of hemostasis in the human fetus and newborn infant. J Pediatr 1971; 79: 838-853
  • 5 Abrol P, Bhargava V, Dube B, Tiwari AD, Sharma A. Hemostasis in healthy neonates. Ind Pediatr 1984; 21: 671-675
  • 6 Bhatia BD, Bhargava V, Chatterjee M, Kota VL N, Singh LI, Jain NP. Studies on foetal growth patterns. Ind Pediatr 1981; 18: 647-653
  • 7 Denson KW E. Reagents and techniques. In “Treatment of haemophilia and other coagulation disorders” Biggs R, Macfarlane RG. (Ed). Blackwell Scientific Publications; Oxford: 1966: 337-375
  • 8 Owen CA, Bowie EJ W, Didisheim P, Thompson JH. The diagnosis of bleeding disorders. J & A Churchill Ltd, London 1969; 89
  • 9 Millar HR, Simpson JG, Stalker AL. An evaluation of the heat precipitation method for plasma fibrinogen estimation. J Clin Pathol 1971; 24: 827-830
  • 10 Hawiger J, Hawiger A, Koenig MG. Staphylococcal clumping and fibrinogen and fibrin degradation products in inflammatory exudate. Proc Soc Exp Biol Med 1971; 136: 132-136
  • 11 Witt I, Müller H, Künzer W. Evidence of existence of foetal fibrinogen. Thrombos Diathes Haemorrh 1969; 22: 101-109
  • 12 Kurkcouglu M, McElfresh AE. The Hageman Factor: Determinations of its concentration during the neonatal period and presentation of a case of Hageman factor deficiency. J Pediatr 1960; 57: 61-64
  • 13 Hilgartner MW, Smith CH. Plasma thromboplastin antecedent (factor XI) in the neonate. J Pediatr 1965; 66: 747-752
  • 14 Kazal LA. Congenital disorders of hemostasis and blood coagulation in infancy. In “The clinical pathology of infancy” Sunderman FW, Sunderman jr FW. (Eds). Springfield III: Charles C Thomas; 1967: 103-117
  • 15 Sell EJ, Corrigan jr JJ. Platelet counts, fibrinogen concentrations and factor V and factor VIII levels in healthy infants according to gestational age. J Pediatr 1973; 82: 1028-1032
  • 16 Rapaport M, Rubin MI, Chaffee D. Fractionation of the serum and plasma proteins by salt precipitation in infants and children. J Clin Invest 1943; 22: 483-486
  • 17 Chessells JM, Wigglesworth JS. Coagulation studies in preterm infants with respiratory distress and intracranial haemorrhage. Arch Dis Child 1972; 47: 564-570
  • 18 Ekelund H, Finnstrom O. Fibrinolysis in preterm infants and in infants small for gestational age. Acta Paediat Scand 1972; 61: 185-196